Advocacy Success Story: Kenya Approves Misoprostol for PPH

Posted on

By: Melissa Wanda Kirowo, Advocacy Project Officer, FCI Program of Management Sciences for Health in Kenya

For the first time, the Kenya Essential Medicines List 2016 included misoprostol in the oxytocics section, indicating its use for the prevention and treatment of postpartum hemorrhage, excessive bleeding after childbirth and a leading cause of maternal death…read more